Five Prime Therapeutics, Inc. Operating Cash Flow
Five Prime Therapeutics, Inc. reported Operating Cash Flow of -$64.65 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-03-22
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$13.27M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was -$15.32M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was -$20.99M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$15.07M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$64.65M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$113.87M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$122.51M.
- Five Prime Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$112.18M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$13.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$28.59M derived: sum of 2 quarters · filed 2021-03-22 | -$49.58M derived: sum of 3 quarters · filed 2021-03-22 | -$64.65M 10-K · filed 2021-03-22 |
| 2020-09-30 | -$15.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$36.32M derived: sum of 2 quarters · filed 2020-11-03 | -$51.39M 10-Q · filed 2020-11-03 | -$81.01M derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-06-30 | -$20.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$36.06M 10-Q · filed 2020-08-06 | -$65.68M derived: sum of 3 quarters · filed 2021-03-22 | -$93.60M derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-03-31 | -$15.07M 10-Q · filed 2020-05-07 | -$44.69M derived: sum of 2 quarters · filed 2021-03-22 | -$72.61M derived: sum of 3 quarters · filed 2021-03-22 | -$96.26M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-12-31 | -$29.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$57.54M derived: sum of 2 quarters · filed 2021-03-22 | -$81.19M derived: sum of 3 quarters · filed 2021-03-22 | -$113.87M 10-K · filed 2021-03-22 |
| 2019-09-30 | -$27.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$51.57M derived: sum of 2 quarters · filed 2020-11-03 | -$84.25M 10-Q · filed 2020-11-03 | -$136.82M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-06-30 | -$23.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$56.33M 10-Q · filed 2020-08-06 | -$108.91M derived: sum of 3 quarters · filed 2021-03-22 | -$139.84M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-03-31 | -$32.68M 10-Q · filed 2020-05-07 | -$85.25M derived: sum of 2 quarters · filed 2021-03-22 | -$116.19M derived: sum of 3 quarters · filed 2021-03-22 | -$144.57M derived: sum of 4 quarters · filed 2021-03-22 |
| 2018-12-31 | -$52.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$83.51M derived: sum of 2 quarters · filed 2021-03-22 | -$111.89M derived: sum of 3 quarters · filed 2021-03-22 | -$122.51M 10-K · filed 2021-03-22 |
| 2018-09-30 | -$30.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$59.31M derived: sum of 2 quarters · filed 2019-11-06 | -$69.94M 10-Q · filed 2019-11-06 | -$97.40M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$28.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$39.00M 10-Q · filed 2019-08-08 | -$66.47M derived: sum of 3 quarters · filed 2020-02-27 | -$94.17M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$10.62M 10-Q · filed 2019-05-09 | -$38.09M derived: sum of 2 quarters · filed 2020-02-27 | -$65.79M derived: sum of 3 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$27.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$55.17M derived: sum of 2 quarters · filed 2020-02-27 | -$112.18M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$27.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$84.72M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$57.02M 10-Q · filed 2018-08-08 | |||
| 2016-12-31 | -$79.75M 10-K · filed 2019-02-26 | |||
| 2014-06-30 | $12.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $6.46M 10-Q · filed 2014-08-07 | -$3.14M derived: sum of 3 quarters · filed 2014-08-07 | -$10.26M derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-31 | -$5.59M 10-Q · filed 2014-05-12 | -$15.19M derived: sum of 2 quarters · filed 2014-05-12 | -$22.31M derived: sum of 3 quarters · filed 2014-05-12 | -$30.80M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-12-31 | -$9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$16.72M derived: sum of 2 quarters · filed 2014-03-26 | -$25.21M derived: sum of 3 quarters · filed 2014-08-07 | -$25.33M 10-K · filed 2014-03-26 |
| 2013-09-30 | -$7.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$15.61M derived: sum of 2 quarters · filed 2014-08-07 | -$15.73M 10-Q · filed 2013-11-13 | -$21.52M derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-06-30 | -$8.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$8.61M 10-Q · filed 2014-08-07 | -$14.41M derived: sum of 3 quarters · filed 2014-08-07 | |
| 2013-03-31 | -$121.00K 10-Q · filed 2014-05-12 | -$5.91M derived: sum of 2 quarters · filed 2014-05-12 | ||
| 2012-12-31 | -$5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$18.40M 10-K · filed 2014-03-26 | ||
| 2012-09-30 | -$12.60M 10-Q · filed 2013-11-13 | |||
| 2011-12-31 | $23.29M 10-K · filed 2014-03-26 |